felodipine has been researched along with Apoplexy in 7 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
Excerpt | Relevance | Reference |
---|---|---|
"In newly diagnosed patients with hypertension, lercanidipine was superior to nifedipine in the six-year period when the analyzed endpoint was stroke." | 7.85 | Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study. ( Cheng, KC; Cheng, KH; Cheng, KY; Lai, WT; Lee, CW; Yang, YH, 2017) |
"In newly diagnosed patients with hypertension, lercanidipine was superior to nifedipine in the six-year period when the analyzed endpoint was stroke." | 3.85 | Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study. ( Cheng, KC; Cheng, KH; Cheng, KY; Lai, WT; Lee, CW; Yang, YH, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, KH | 1 |
Cheng, KC | 1 |
Cheng, KY | 1 |
Yang, YH | 1 |
Lee, CW | 1 |
Lai, WT | 1 |
Zhang, Y | 2 |
Zhang, X | 2 |
Liu, L | 2 |
Zanchetti, A | 2 |
Jönsson, B | 1 |
Hansson, L | 1 |
Stålhammar, NO | 1 |
Liu, G | 1 |
Li, W | 1 |
Modeliard, SS | 1 |
Serot, JM | 1 |
Mansour, J | 1 |
Achard, JM | 1 |
Fournier, A | 1 |
Soucek, M | 1 |
Plachý, M | 1 |
Fischberg, GM | 1 |
Lozano, E | 1 |
Rajamani, K | 1 |
Ameriso, S | 1 |
Fisher, MJ | 1 |
4 trials available for felodipine and Apoplexy
Article | Year |
---|---|
Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study.
Topics: Age Factors; Aged; Antihypertensive Agents; Asian People; Blood Pressure; Cardiovascular Diseases; C | 2010 |
Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost-effectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension.
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Pressure; Calcium Channel Blockers; Cost-Benefit Analy | 2003 |
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Ch | 2005 |
[The FEVER (Felodipine EVEnt Reduction) trial; a randomised, double-blind, placebo-controlled trial in Chinese hypertensive patients].
Topics: Aged; Calcium Channel Blockers; China; Diuretics; Double-Blind Method; Felodipine; Female; Humans; H | 2007 |
3 other studies available for felodipine and Apoplexy
Article | Year |
---|---|
Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study.
Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Dihyd | 2017 |
FEVER study: a trial further supporting the concept of a blood pressure-independent stroke protective effect by dihydropyridines.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Felodipine; Female; Heart Rate; Hum | 2006 |
Stroke precipitated by moderate blood pressure reduction.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Emergency Treatment; Felodipine; Female; Humans; Hyp | 2000 |